Description
Mechanism of Action:
✔ Vildagliptin: Enhances GLP-1 and GIP activity, stimulating insulin release and lowering glucagon levels.
✔ Metformin: Decreases hepatic glucose production, delays intestinal glucose absorption, and enhances insulin action.
Indications:
✔ Type 2 Diabetes Mellitus (when diet and exercise alone are not sufficient)
✔ Patients requiring dual therapy for better glucose control
Key Benefits:
✅ Dual-action therapy for superior blood sugar management
✅ Reduces insulin resistance and enhances insulin secretion
✅ Weight-neutral and low risk of hypoglycemia
✅ Once or twice-daily dosing for better compliance
Dosage & Administration:
- Recommended Dosage: One tablet twice daily or as prescribed.
- Route of Administration: Oral
- Food Intake: Take with meals to reduce gastrointestinal side effects.
Precautions & Warnings:
- Not recommended for patients with severe kidney disease.
- Monitor liver function in long-term therapy.
- Avoid excessive alcohol consumption.
Possible Side Effects:
- Mild nausea or diarrhea (common with metformin)
- Headache
- Hypoglycemia (rare)
Storage & Packaging:
- Store below 30°C in a cool, dry place.
- Available in blister packs and bulk packaging.
Manufacturing & Regulatory Compliance:
Manufactured by Aetos Life Care in WHO-GMP certified facilities, ensuring compliance with EU-GMP standards.
Global Export & Supply:
Aetos Life Care exports Vildagliptin 50 mg + Metformin 500 mg Tablets to Latin America, Africa, Asia, Europe, and CIS countries, delivering affordable and high-quality diabetes management solutions worldwide.
